References:
1. Kuczmarski RJ, Carroll MD, Flegal KM, Troiano RP. Varying body mass
index cutoff points to describe overweight prevalence among U.S. adults: NHANES III (1988 to
1994). Obes Res 1997;5:542–8.
2. Mokdad AH, Serdula MK, Dietz WH, et al. The continuing epidemic of
obesity in the United States. JAMA 2000;284:1650–1 [letter].
3. Lewis CE, Jacobs DR Jr, McCreath H, et al. Weight gain continues in
the 1990s: 10-year trends in weight and overweight from the CARDIA study. Coronary Artery Risk
Development in Young Adults. Am J Epidemiol 2000;151:1172–81.
4. Fine JT, Colditz GA, Coakley EG, et al. A prospective study of weight
change and health-related quality of life in women. JAMA 1999;282:2136–42.
5. Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality
in a prospective cohort of U.S. adults. N Engl J Med 1999;341:1097–105.
6. Salamone LM, Cauley JA, Black DM, et al. Effect of a lifestyle
intervention on bone mineral density in premenopausal women: a randomized trial. Am J Clin
Nutr 1999;70:97–103.
7. Knopp RH, Walden CE, Retzlaff BM, et al. Long-term
cholesterol-lowering effects of 4 fat-restricted diets in hypercholesterolemic and combined
hyperlipidemic men. The Dietary Alternatives Study. JAMA 1997;278:1509–15.
8. Willett WC. Dietary fat and obesity: an unconvincing relation. Am
J Clin Nutr 1998;68:1149–50.
9. Andersson I, Lennernas M, Rossner S. Meal pattern and risk factor
evaluation in one-year completers of a weight reduction program for obese men - the
‘Gustaf’ study. J Intern Med 2000;247:30–8.
10. Duncan KH, Bacon JA, Weinsier RL. The effects of high and low energy
density diets on satiety, energy intake, and eating time of obese and nonobese subjects.
Am J Clin Nutr 1983;37:763–7.
11. Marquette CJ Jr. Effects of bulk producing tablets on hunger
intensity in dieting patients. Obes Bariatr Med 1976;5(3):84–8.
12. Rossner S, von Zweigbergk D, Ohlin A, Ryttig K. Weight reduction with
dietary fibre supplements. Acta Med Scand 1987;222:83–8.
13. Biancardi G, Palmiero L, Ghirardi PE. Glucomannan in the treatment of
overweight patients with osteoarthritis. Curr Ther Res 1989;46:908–12.
14. Hylander B, Rössner S. Effects of dietary fiber intake before
meals on weight loss and hunger in a weight-reducing club. Acta Med Scand
1983;213:217–20.
15. Randolph TG. Masked food allergy as a factor in the development and
persistence of obesity. J Lab Clin Med 1947;32:1547.
16. Muls E, Kempen K, Vansant G, et al. Is weight cycling detrimental to
health? A review of the literature in humans. Int J Obes
1995;19(3):S46–S50.
17. Roberts SB. High-glycemic index foods, hunger, and obesity: is there
a connection? Nutr Rev 2000;58:163–9 [review].
18. Wadden TA, Berkowitz RI, Sarwer DB, et al. Benefits of lifestyle
modification in the pharmacologic treatment of obesity. A randomized trial. Arch Intern
Med 2001;161:218–27.
19. Racette SB, Schoeller DA, Kushner RF, Neil KM. Exercise enhances
dietary compliance during moderate energy restriction in obese women. Am J Clin Nutr
1995;62:345–9.
20. [No authors listed]. Effect of exercise alone on obesity. Br Med
J 1976;1:417–8.
21. Votruba SB, Horvitz MA, Schoeller DA. The role of exercise in the
treatment of obesity. Nutrition 2000;16:179–88.
22. Votruba SB, Horvitz MA, Schoeller DA. The role of exercise in the
treatment of obesity. Nutrition 2000;16:179–88.
23. National Task Force on the Prevention and Treatment of Obesity.
Dieting and the Development of Eating Disorders in Overweight and Obese Adults. Arch
Intern Med 2000;160:2581–9.
24. Pi-Sunyer FX. Obesity. In Shils ME, Olson JA, Shike M, Ross AC, eds.
Modern Nutrition in Health and Disease, 9th ed. Baltimore: Williams and Wilkins,
1999, 1410.
25. Stanko RT, Tietze DL, Arch JE. Body composition, energy utilization,
and nitrogen metabolism with a 4.25-MJ/d low-energy diet supplemented with pyruvate. Am J
Clin Nutr 1992;56:630–5.
26. Stanko RT, Reynolds HR, Hoyson R, et al. Pyruvate supplementation of
a low-cholesterol, low-fat diet: Effects on plasma lipid concentration and body composition in
hyperlipidemic patients. Am J Clin Nutr 1994;59:423–7.
27. Kalman D, Colker CM, Wilets I, et al. The effects of pyruvate
supplementation on body composition in overweight individuals. Nutrition
1999;15:337–40.
28. Kalman D, Colker CM, Stark S, et al. Effect of pyruvate
supplementation on body composition and mood. Curr Ther Res
1998;59:793–802.
29. Kreider R, Koh P, Ferreira M, et al. Effects of pyruvate
supplementation during training on body composition & metabolic responses to exercise.
Med Sci Sports Exerc 1998;30:S62 [abstract].
30. Ivy JL, Cortez MY, Chandler RM, et al. Effects of pyruvate on the
metabolism and insulin resistance of obese Zucker rats. Am J Clin Nutr
1994;59:331–7.
31. Ceci F, Cangiano C, Cairella M, et al. The effects of oral
5-hydroxytryptophan administration on feeding behavior in obese adult female subjects. J
Neural Transm 1989;76:109–17.
32. Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence
to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J
Clin Nutr 1992;56:863–7.
33. Cangiano C, Ceci F, Cairella M, et al. Effects of 5-hydroxytryptophan
on eating behavior and adherence to dietary prescriptions in obese adult subjects. Adv Exp
Med Biol 1991;294:591–3.
34. Cangiano C, Ceci F, Cascino A, et al. Eating behavior and adherence
to dietary prescriptions in obese adult subjects treated with 5-hydroxytryptophan. Am J
Clin Nutr 1992;56:863–7.
35. Cangiano C, Laviano A, Del Ben M, et al. Effects of oral
5-hydroxy-tryptophan on energy intake and macronutrient selection in non-insulin dependent
diabetic patients. Int J Obes Relat Metab Disord 1998;22:648–54.
36. Colker CM, Torina GC, Swain MA, Kalman DS. Double-blind study
evaluating the effects of exercise plus 3-acetyl-7-oxo-dehydroepiandrosterone on body
composition and the endocrine system in overweight adults. J Exercise Physiology
Online 1999;2(4).
37. He Z-Q, Phone ZS. Body weight reduction in adolescents by a
combination of measures including using L-carnitine. Acta Nutrimenta Sinica
1997;19(2).
38. Becher EW, Jakober B, Luft D, et al. Clinical and biochemical
evaluations of the alga spirulina with regard to its application in the treatment of obesity.
A double-blind cross-over study. Nutr Rep Intl 1986;33:565–73.
39. Anderson RA. Effects of chromium on body composition and weight loss.
Nutr Rev 1998;56:266–70.
40. Bahadori B, Wallner S, Schneider H, et al. Effect of chromium yeast
and chromium picolinate on body composition of obese, non-diabetic patients during and after a
formula diet. Acta Med Austriaca 1997;24:185–7
41. Trent LK, Thieding-Cancel D. Effects of chromium picolinate on body
composition. J Sports Med Phys Fitness 1995;35:273–80
42. Lowenstein JM. Effect of (-)-hydroxycitrate on fatty acid synthesis
by rat liver in vivo. J Biol Chem 1971;246:629–32.
43. Triscari J, Sullivan AC. Comparative effects of (-)-hydroxycitrate
and (+)-allo-hydroxycitrate on acetyl CoA carboxylase and fatty acid and cholesterol synthesis
in vivo. Lipids 1977;12:357–63.
44. Cheema-Dhadli S, Harlperin ML, Leznoff CC. Inhibition of enzymes
which interact with citrate by (-)hydroxycitrate and 1,2,3,-tricarboxybenzene. Eur J
Biochem 1973;38:98–102.
45. Sullivan AC, Hamilton JG, Miller ON, et al. Inhibition of lipogenesis
in rat liver by (-)-hydroxycitrate. Arch Biochem Biophys 1972;150:183–90.
46. Greenwood MRC, Cleary MP, Gruen R, et al. Effect of
(-)-hydroxycitrate on development of obesity in the Zucker obese rat. Am J Physiol
1981;240:E72–8.
47. Sullivan AC, Triscari J. Metabolic regulation as a control for lipid
disorders. Am J Clin Nutr 1977;30:767–76.
48. Sullivan AC, Triscari J, Hamilton JG, et al. Effect of
(-)-hydroxycitrate upon the accumulation of lipid in the rat: I. Lipogenesis. Lipids
1974;9:121–8.
49. Sullivan AC, Triscari J, Hamilton JG, et al. Effect of
(-)-hydroxycitrate upon the accumulation of lipid in the rat: II. Appetite. Lipids
1974;9:129–34.
50. Heymsfield SB, Allison DB, Vasselli JR, et al. Garcinia cambogia
(hydroxycitric acid) as a potential antiobesity agent: a randomized controlled trial.
JAMA 1998;280:1596–600.
51. Martinet A, Hostettmann K, Schultz Y. Thermogenic effects of
commercially available plant preparations aimed at treating human obesity.
Phytomedicine 1999;6:231–8.
52. Diamond P, Cusan L, Gomez J-L, et al. Metabolic effects of 12-month
percutaneous dehydroepiandrosterone replacement therapy in postmenopausal women. J
Endocrinol 1996;150:S43–50.
53. Nestler JE, Barlasini CO, Clore JN, et al. Dehydroepiandrosterone
reduces serum low density lipoprotein levels and body fat but does not alter insulin
sensitivity in normal men. J Clin Endocrinol Metab 1988;66:57–61.
54. Welle S, Jozefowicz R, Statt M. Failure of DHEA to influence energy
and protein metabolism in humans. J Clin Endocrinol Metab 1990;71:1259.
55. Usiskin KS, Butterworth S, Clore JN, et al. Lack of effect of
dehydroepiandrosterone in obese men. Int J Obes 1990;14:457–63.
56. Vogiatzi MG, Boeck MA, Vlachopapadopoulou E, et al.
Dehydroepiandrosterone in morbidly obese adolescents: effects on weight, body composition,
lipids, and insulin resistance. Metabolism 1996;45:1101–15.
57. Yen SSC, Morales AJ, Khorram O. Replacement of DHEA in aging men and
women. Ann NY Acad Sci 1995;774:128–42.
58. Werbach MR, Murray MT. Botanical Influences on Illness.
Tarzana, CA: Third Line Press, 2000, 476–80.
59. Martinet A, Hostettmann K, Schultz Y. Thermogenic effects of
commercially available plant preparations aimed at treating human obesity.
Phytomedicine 1999;6:231–8.
60. Breum L, Pedersen JK, Ahlstrom F, et al. Comparison of an
ephedrine/caffeine combination and dexfenfluramine in the treatment of obesity. A double-blind
multi-centre trial in general practice. Int J Obes Relat Metab Disord
1994;18:99–103.
61. Toubro S, Astrup A, Breum L, et al. The acute and chronic effects of
ephedrine/caffeine mixtures on energy expenditure and glucose metabolism in humans. Int J
Obes Relat Metab Disord 1993;17(suppl 3):73–7.
62. Yoshioka M, St-Pierre S, Drapeau V, et al. Effects of red pepper on
appetite and energy intake. Br J Nutr 1999;82:115–23.
63. Yoshioka M, St-Pierre S, Suzuki M, Tremblay A. Effects of red pepper
added to high-fat and high-carbohydrate meals on energy metabolism and substrate utilization
in Japanese women. Br J Nutr 1998;80:503–10.
64. Buck SH, Burks TF. The neuropharmacology of capsaicin: review of some
recent observations. Pharmacol Rev 1986;38:179–226 [review].
65. Tremblay A. Obesity and health: what can we learn from intervention
studies? [abstract]. Paper presented to the Australian Society for the Study of Obesity, 8th
Annual Meeting, Sydney, 1999. ASSO Proceedings, Melbourne: ASSO, 1999, 38.
66. Leung A, Foster S. Encyclopedia of Common Natural Ingredients
Used in Food, Drugs, and Cosmetics, 2d ed. New York: John Wiley & Sons, 1996,
293–4.
67. Astrup A, Breum L, Toubro S, et al. The effect and safety of an
ephedrine/caffeine compound compared to ephedrine, caffeine and placebo in obese subjects on
an energy restricted diet. A double blind trial. Int J Obes Relat Metab Disord
1992;16:269–77.
68. Dulloo AG, Duret C, Rohrer D, et al. Efficacy of a green tea extract
rich in catechin polyphenols and caffeine in increasing 24-h energy expenditure and fat
oxidation in humans. Am J Clin Nutr 1999;70:1040–5.
69. Antonio J, Colker CM, Torina GC, et al. Effects of a standardized
guggulsterone phosphate supplement on body composition in overweight adults: A pilot study.
Curr Ther Res 1999;60:220–7.
70. Bone K. Clinical Applications of Ayurvedic and Chinese
Herbs. Warwick, Queensland, Australia: Phytotherapy Press, 1996, 103–7.
71. Colker CM, Kalman DS, Torina GC, et al. Effects of Citrus
aurantium extract, caffeine, and St. John’s wort on body fat loss, lipid levels,
and mood states in overweight healthy adults. Curr Ther Res 1999;60:145–53.
72. Turnbull WH, Thomas HG. The effect of Plantago ovata
seed-containing preparation on appetite variables, nutrient and energy intake. Int J Obes
Metab Disord 1995;19:338–42.